Impact of Semaglutide 2.4 mg on body composition and function: The SEMALEAN study shows 13% weight loss at 12 months with preserved lean mass, improved grip strength, and reduced sarcopenic obesity. Functional and metabolic health improved alongside fat loss.
https://t.co/Y6BfXDCPtl
@TheAACE 2025 here we come! Aunque parezca increíble en un hospital público en un país con recursos muy limitados. Experiencia con el uso de monitoreo continuo de glucosa ! #cgmforall@ScarletRodas@TaniaAleD ,Sebastián Manzanarez y Karla Mendoza teamwork!